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Leaves of Euphorbia hirta used in traditional medicine for the treatments of boils, wounds and control 
of diarrhoea and dysentery were extracted by maceration in ethanol. The agar diffusion method was 
used to determine the antibacterial activity against Staphylococcus aureus, Escherichia coli, 
Pseudomonas aeruginosa, Salmonella typhi and Bacillus subtilis at different concentrations while 
toxicological studies was carried out through intraperitoneal injection of albino rat with varying 
concentrations of the extract. Antibacterial sensitivity test indicated that the extract inhibited the 
growth of S. aureus, E. coli, B. subtilis and P.  aeruginosa to varying degrees while S. typhi was not 
affected. Minimum inhibitory concentration (MIC), of the extract against E. coli, S aureus, P. aeruginosa 
and B. subtilis were 58.09, 22.55, 57.64 and 74.61 mg/ml respectively. Hematological analyses revealed 
that there was no significant difference (p = 0.05) between the total red blood cells (RBC), white blood 
cells (WBC), hemoglobin (Hb) and mean corpuscular hemoglobin concentration (MCHC) values of the 
rats used as control and those treated with the different concentrations of the extract. Also, the 
erythrocyte sedimentation rate (ESR) and mean corpuscular volume (MCV) values were significantly 
different at certain concentrations of the extract administered which indicates that the plant extract is 
heamatologically not toxic to rats. The plant extract was found to contain tannins, alkaloids and 
flavonoids which may be responsible for its antimicrobial properties. The results justify the traditional 
use of the plant in the treatment of sores, boils, wounds and control of dysentery and diarrhoea. 
 





Euphorbia hirta belongs to the family Euphorbiaceae. It is 
a small annual herb common to tropical countries 
(Soforowa, 1982). It can grow to a height of 40 cm.  The 
stem is slender and often reddish in colour, covered with 
yellowish bristly hairs especially in the younger parts. The 
leaves are oppositely arranged, lanceolate and are usual-
ly greenish or reddish underneath measuring about 5 cm 
long. In the axils appear very small dense round clusters 
of flowers. The small green flowers constitute the inflore-
scence characteristic of the euphorbias. The stem and 
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Tallantire, 1971; Anononymous, 2005). 
In East and West Africa, extracts of the plant are used 
in treatment of asthma and respiratory tract inflam-
mations (Kokwaro, 1993). It is also used for coughs, 
chronic bronchitis and other pulmonary disorders in 
Mauritius (Wong-Ting-Fook, 1980). The plant is also 
widely used in Angola against diarrhea and dysentery, 
especially amoebic dysentery. In Nigeria, extracts or 
exudates of the plant are used as ear drops and in the 
treatment of boils, sore and promoting wound healing 
(Igoli et al., 2005, Annon, 2005). Interaction with some 
traditional medical practitioners revealed that the plant is 
very popular amongst them, thus there is need to 
determine its antibacterial potentials. This work was 
therefore undertaken to authenticate the antibacterial 






MATERIALS AND METHODS 
 
Sample preparation and extraction procedure 
 
Fresh leaves of E. hirta were collected from Umuguma, Owerri 
West Local Government Area of Imo State, Nigeria. The plant was 
identified by Dr. I. I. Ibeawuchi of the Department of Crop Science 
Technology, Federal University of Technology, Owerri. Voucher 
specimens were also kept with number E.h.cco 002. 
The fresh leaves were air dried for about one week and ground 
into fine powder using a mechanical grinder. 20 g of the fine powder 
were weighed into 250 ml of ethanol (95%) in a conical flask. This 
was covered, shaken every 30 min for 6 h and then allowed to 
stand for about 48 h. The solution was subsequently shaken and 
filtered using Whatman filter paper. The filtrate was evaporated to 
dryness using a rotary evaporator (Model type 349/2, Corning 
Limited.). A yield of 9.1% was obtained. The extract was then 
stored below ambient temperature. 
The methods of Akujobi et al. (2004) and Esimone et al. (1998) 
were adopted For the preparations of dilutions of crude extract for 
antibacterial assay. The crude extracts were dissolved in 30% 
dimethylsulphoxide (DMSO) and further diluted to obtain 250, 200, 




Evaluation of antimicrobial activity 
 
Escherichia coli, Staphylococcus aureus, Salmonella typhi and 
Pseudomonas aeruginosa were obtained from the Federal Medical 
Centre, Owerri while Bacillus subtilis was isolated from fermented 
African Oil bean seeds. They were re-isolated and the pure cultures 
subcultured on Nutrient agar slants. They were stored at 4oC until 
required. 
The agar diffusion method as described by Esimone et al. (1998) 
was adopted for the study. About 15 ml of sterile molten nutrient 
agar in a Petri dish was seeded with 1.0 ml of standardized broth 
cultures of the bacteria (1.0 x 107 cfu/ml) and swirled gently to 
ensure uniform distribution of the microorganisms and then allowed 
to solidify on a flat surface. Three holes were made in the plates 
(about 5.0 mm diameter) using a sterile cork borer and equal volu-
mes of the extracts were transferred into the holes using a Past-
eur’s pipette. Two Petri dishes containing a particular microorga-
nism were used for each concentration of the extract. The plates 
were allowed to stand for one hour for prediffusion of the extract to 
occur (Esimone et al., 1998) and were incubated at 37oC for 24 h. 
At the end of incubation, zones of inhibition that developed were 
measured and the average of zones of inhibition was calculated. 
The minimum inhibitory concentration (MIC) was calculated by 
plotting the natural logarithm of the concentration of extract against 
the square of zones of inhibition. A regression line was drawn 
through the points. The antilogarithm of the intercept on the 
logarithm of concentration axis gave the MIC values (Esimone et 
al., 1998; Osadebe and Ukwueze, 2004). 
 
 
Administration to rats 
 
Initial LD50 studies carried out were used to determine the maximum 
dose that did not produce any death in rats. Four groups of albino 
rats each comprising three rats, randomly selected having an 
average weight of 132.5 g were used. They were placed in different 
cages. Based on the LD50 studies, doses of 60.4 body weight, 
120.8 body weight, 241.5 body weight and 483.0 mg/kg body 
weight were intraperitoneally injected into each group of the rats 
(Iyaniwura et al., 1991, EFPIA/ECVAM,  2001).  The  administration  




of the injection was carried out on daily basis for 14 days 
(EFPIA/ECVAM, 2001). The control group was injected with the 
diluents (30% DMSO). Food and water were provided ad libitum. 
On the 15th day, blood samples drawn through the sublingual 
vein according to the method described by Zeller et al. (1998). This 
method has been found to be suitable for laboratory animal’s well 
being as stated in EFPIA/ECVAM (2001). Two milliliter of blood 
sample was immediately transferred to ethylene diamine tetracetic 
acid (EDTA) treated bottles for hematological assay. 
Blood samples were analyzed within 3 h of collection for total red 
blood cells (RBC), white blood cells (WBC), packed cell volume 
(PCV), hemoglobin (Hb) content, serum glutamic oxaloacetic tran-
saminase (SGOT) and serum glutamics (2003). Erythrocyte sedi-
mentation rate (ESR) was determined according to the method 
described by Orji et al. (1986). Various hematological indices were 
calculated from the results obtained. These included mean corpus-
cular volume (MCV), mean corpuscular hemoglobin (MCH) and 
mean corpuscular hemoglobin concentration (MCHC). 
 
 
Preliminary phytochemical analysis of extract 
 
This was carried out according to the methods described by Trease 





The data obtained from the study were analyzed statistically using 
the analysis of variance (ANOVA). Fisher’s Least Significant 





Results of the antibacterial screening of the different 
concentrations of the extract on the test isolates are 
shown in Table 1. The results show that increase in 
concentration of extract increased the zone of growth 
inhibition of some of the microorganisms.  The extract did 
not inhibit the growth of S. typhi at any of the concen-
trations administered. The highest zone of growth inhibi-
tion of 13.5 mm diameter was exhibited by 250 mg/ml 
concentration of the extract against S. aureus. Only the 
200 and 250 mg/ml concentrations had effects against B. 
subtilis while at 50 mg/ml the extract had no effect 
against E. coli and P. aeruginosa. The lowest zone of 
growth inhibition was observed with 200 mg/ml concen-
tration of the extract against B. subtilis which gave a zone 
of inhibition measuring 5.6 mm. 
The minimum inhibitory concentrations of the extract on 
the test isolates are shown in Table 2. The lowest mini-
mum inhibitory concentration (MIC) was produced again-
st S. aureus with a concentration of 22.55 mg/ml while 
the highest MIC was against B. subtilis with a concen-
tration of 74.61 mg/ml. The extract had MIC of 58.09 and 
57.64 mg/ml, respectively, against E. coli and P. 
aeruginosa. 
Table 3 shows the results of the hematological analy-
ses of the blood samples of rats injected with different 
concentrations of the extracts. In general although the 
values obtained for RBC counts,  total  WBC  counts,  Hb  




Table 1. Antibacterial screening of the different concentrations of crude ethanolic extract of Euphorbia hirta. 
 
Zones of inhibition (mm) Concentrations of 
extract (mg/ml) E. coli S. aureus P. aeruginosa B. subtilis S. typhi 
250 11.9a 13.5b 12.1a 8.4c NI 
200 9.8a 12.9b 11.3c 5.6d NI 
150 8.0a 11.5b 8.2a NI NI 
100 5.8a 10.6b 6.1a NI NI 
50 NI 7.8a NI NI NI 
 
*Values are means of triplicate readings. NI = No inhibition.  




Table 2. Minimum inhibitory concentrations of the ethanolic extract of Euphorbia hirta against test isolates. 
 
Plant E. coli S. aureus P. aeruginosa B. subtilis Sa. typhi 
E. hirta  59.09a 22.55b 57.64a 74.61a NIL 
 




Table 3. Hematological analysis of blood samples of rats injected with different concentrations of crude ethanolic 
extract of Euphorbia hirta. 
 
Concentrations of extract injected (mg/kg body weight) 
Parameters 
Control 60.4 120.8 241.5 483.0 SEM LSD 
RBC (x106 cells/mm3) 5.32a 5.28a 4.96a 4.84a 4.68a 0.43 0.96 
PCV (%) 36.3a 32.0b 32.0b 33.0b 33.0b 0.49 1.09 
ESR (mm/h) 3.50 a 4.0a,b 4.0a,b 4.0a,b 5.0b 0.639 1.42 
MCV (cubic microns) 68.23 a 60.61b 64.52c 68.18a 70.51a 1.076 2.40 
Hb content (g/100 ml) 9.8 a 9.1a 9.1a 9.2a 9.3a 0.341 0.76 
MCHC (%) 27.0 a 28.44a 28.44a 27.88a 28.18a 0.847 1.89 




level and MCHC differed. They were not significantly 
different (p  0.05) from the values obtained from the 
control for these parameters. For ESR, the value obtain-
ed from the rats treated with 483.0 mg/kg body weight of 
extract was significantly different from the value obtained 
from control but not different from those rats treated with 
the other concentrations. Also MCV values from rats 
treated with 60.4 body weight and 120.8 mg/kg body 
weight concentrations of the extract were significantly 
different (p = 0.05) from the values of control and others. 
The results of the preliminary phytochemical screening 
are shown in Table 4. The extract was found to contain 
tannins, flavonoids, alkaloids and cardiac glycosides.  No 





In this study, the results obtained indicated that the 
ethanolic extract of the E.  hirta inhibited the growth of the 
test isolates except S. typhi. This, therefore, shows that 
the extract contains substance(s) that can inhibit the 
growth of some microorganisms. Other workers have 
also shown that extracts of some plants inhibited the 
growth of various microorganisms at different concentra-
tions (Akujobi et al., 2004; Esimone et al., 1998; Nweze 
et al., 2004; Ntiejumokwu and Alemika, 1991; Osadebe 
and Ukwueze, 2004). The observed antibacterial effects 
on the isolates is believed to be due to the presence of 
alkaloids, tannins and flavonoids which have been shown 
to posses antibacterial properties (Cowan, 1999; 
Draughon, 2004). Some workers have also attributed 
their observed antimicrobial effects of plant extracts to 
the presence of these secondary metabolites (Nweze et 
al., 2004).  Some workers have also identified tannins, 
flavonoids and alkaloids in the extracts of some medicinal 
plant (Yoshida et al., 1990; Blanc and Sacqui-Sannes, 
1972; Abo, 1990; Baslas and Agarwal, 1980). 
The observed antibacterial properties corroborate its 
use in traditional medicine.  Traditionally, extracts of the 
plant are used in sore and wound healing, as ear drop for 
boils in the ear and treatment of boils. They are also used  




Table 4. Preliminary phytochemical screening of ethanolic extract of Euphorbia hirta. 
 
Plant Saponins Tannins Flavonoids Alkaloids Cardiac glycosides Cyanogenic glycosides 
E. hirta - + + + + - 
 




in the control of diarrhoea and dysentery (Kokwaro, 1993; 
Igoli et al., 2005). The large zones of inhibition exhibited 
by the extract against S. aureus and P. aeruginosa 
justified their use by traditional medical practitioners in 
the treatment of sores, bores and open wounds. S. 
aureus and P. aeruginosa have been implicated in cases 
of boils, sores and wounds (Braude, 1982). Also the 
moderate growth inhibition against E. coli justifies its use 
in the control of diarrhoea and dysentery. E. coli is the 
common cause of traveler’s diarrhoea and other diarrhea-
genic infections in humans (Adams and Moss, 1999). The 
low MIC exhibited by the extract against S.  aureus is of 
great significance in the health care delivery system, 
since it could be used as an alternative to orthodox anti-
biotics in the treatment of infections caused by these 
microbes, especially as they frequently develop resist-
ance to known antibiotics (Singleton, 1999). Their use 
also will reduce the cost of obtaining health care. The 
relatively high zone of inhibition exhibited by the extract 
against E. coli is also of significance, since E. coli is a 
common cause of diarrhea in developing countries.   
The inability of the extract to inhibit Salmonella typhi 
may be that it possesses a mechanism for detoxifying the 
active principles in the extract. Some bacteria are known 
to posses mechanisms by which they convert substances 
that inhibit their growth to non-toxic compounds. For 
examples S. aureus produces the enzyme penicillinase 
which converts the antibiotic penicillin to penicillinoic acid 
which is no longer inhibitory to its growth (Singleton, 
1999). 
Statistical analysis revealed that for RBC there was no 
significant (p  0.05) between the values obtained for the 
different concentrations of the extract injected and the 
control. This shows that the extract did not affect either 
the circulating red blood cells or the erythropoetic centres 
of the animals. Some workers (Aniagu et al., 2005) have 
also shown that some extracts of plants do not have 
deliterious effects on RBC even up to 400 mg/kg body 
weight after 28 days of administration. This is also true 
for the WBC counts. Thus, the extract did not induce 
production or destruction of the WBC. The same trend 
was also observed for the Hb content which indicates that 
the extract did not affect synthesis of hemoglobin by the 
animals. Some plants have been suggested to interfere 
with the synthesis of Hb by inhibition of the uptake and 
utilization of iron (Sokunbi and Egbunike, 2000, 
Iheukwumere et al., 2002).  
These results indicate that the extract is less toxic 
heamatologically, at least to the rats, at the concentra-
tions administered. E. hirta is commonly used traditionally 
in the treatment of wounds and boils as well as in the 
control of diarrhoea and dysentery in Nigeria (Igoli et al., 
2005). However, more work needs to be carried out to 
determine the chemistry of the particular active principle 
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